Fairfax Neonatal Associates

Recent papers from Fairfax Neonatal Associates

1. Cefiderocol to Treat Multidrug-resistant Klebsiella pneumoniae Sepsis, Meningitis and Ventilator-associated Pneumonia in an Extremely Preterm NeonateThe Pediatric Infectious Disease Journal · 2026
2. Empirically Supported Couple Therapy Models for Couple Relationship Distress: A Replication and UpdateJournal of Marital and Family Therapy · 2026
3. Liver Biopsy in Metabolic Dysfunction‐Associated Steatohepatitis Clinical Trials: Potential Pitfalls and SolutionsLiver International · 2026
4. Long-term evolution of pH and metals (Al, Fe, Mn, U) in pyrite-bearing waste rocks using reactive transport modeling: Dealing with stock and process uncertaintiesJournal of Geochemical Exploration · 2026
5. Multidimensional and Burgeoning Leadership: Literacy and MultilingualismEducation Sciences · 2026
6. Beyond hypoxic–ischemic encephalopathy: genetic insights and precision diagnosis in neonatal encephalopathiesFrontiers in Medicine · 2026
7. A phase 1/2, first-in-human, open-label, dose-escalation and -expansion study of TAK-188, a novel antibody-drug conjugate (ADC) targeting CCR8 ⁺ regulatory T cells, in adult patients with locally advanced or metastatic solid tumors.Journal of Clinical Oncology · 2026
8. A phase 1, first-in-human (FIH), dose-escalation and dose-optimization study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 T-cell engager in participants with advanced or metastatic microsatellite-stable (MSS)/microsatellite instability–low (MSI-L) colorectal cancer (CRC).Journal of Clinical Oncology · 2026
9. Phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of TGW101 in patients with advanced solid tumors.Journal of Clinical Oncology · 2026
10. First-in-human study of DM005, an anti-EGFR/c-MET bispecific antibody-drug conjugate, in patients with advanced solid tumors.Journal of Clinical Oncology · 2026
11. Barriers and facilitators to genetic counseling service availability in the Arab world: A genetic counselors' perspectiveJournal of Genetic Counseling · 2026
12. Long-term B-cell depletion with rituximab in relapsing, refractory and severe lupus nephritis: a retrospective case seriesClinical Kidney Journal · 2026
13. Proton Therapy for Head and Neck Adenoid Cystic Carcinoma: A Multi-Institutional ReviewInternational Journal of Particle Therapy · 2026
14. “It All Comes Full Circle”: The Impact of Multilingual Literacy Pedagogies With Teachers, Students, and FamiliesReading Research Quarterly · 2026
15. 147TiP BNT326-02: A phase Ib/II trial of BNT326/YL202 (HER3 ADC) with pumitamig (PD-L1 × VEGF-A bsAb) in non-small cell lung cancer (NSCLC)ESMO Open · 2026
16. Identifying heart rate characteristics of sleep states of preterm infants using video analysisScientific Reports · 2026
17. Abstract PS1-09-17: Phase 1 Clinical Testing of a First-in-Class Antisense Oligonucleotide Therapeutic against Advanced Solid Tumors of Multiple Tissue OriginsClinical Cancer Research · 2026
18. Abstract PS4-06-17: First clinical data of DB-1310 (HER3-targeted antibody-drug-conjugate), in patients with pretreated hormone receptor-positive/HER2-negative breast cancer: efficacy and safety data from a phase 1/2a trialClinical Cancer Research · 2026
19. Bidirectional relations between the maternal and infant gut microbiome and behaviorPediatric Research · 2025
20. A model for global health education through the Ethiopian newborn quality improvement ECHO initiativeJournal of Perinatology · 2025